New York, December 2021: Axiom Market Research & Consulting™ added a report on aptamers market which includes study on coating type, application, end user, and geography. Aptamers market was projected to grow at a CAGR of 17.03% for the forecast period 2021 to 2027. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the aptamers market.
The factors such as strong trend of the research and development investments in the pharmaceutical and biotechnology companies, along with the increasing use of the aptamers as the biosensors, where these aptamers function as the molecular recognition probe for the detection of the targeted molecule in the process of bio imaging, gene therapy and targeted diagnostics, low cost and high efficiency of aptamers has been propelling the growth of the aptamers market during the forecast period.
The report analyses the aptamers market based on the type, technology, application, end user, and geography. By type, the aptamers market is segmented into nucleic acid aptamers, and peptide aptamers. By technology, the aptamers market is segmented into SELEX and other technologies. By application, the aptamers market is segmented into diagnostics, therapeutics development, research and development. By end user, the aptamers market is segmented into academic and government research institutes, biotechnology and pharmaceutical companies, and contract research organizations. Geographically, the aptamers market is studied for the regions including North America, Europe, Asia Pacific, and Rest of the World.
The nucleic acid type segment is further bifurcated into the DNA-based aptamers, RNA-based aptamers, and the XNA-based aptamers. The DNA-based aptamers has been estimated to have high demand as they can selectively bind to the specific target, which is including the protein, carbohydrates, small molecules and Peptides owing to the growth of the segment in the market during the forecast period.
The SELEX techniques have been majorly used in the molecular biology for the production of the oligonucleotides of either the single stranded DNA or RNA that has been specifically bind to the targeted ligands, owning to the growth of the segment in the aptamers market during the forecast period.
The factors such as increasing use of the aptamers for the treatment of the infectious diseases, along with providing fast and accurate results have been contributing to the growth of the segment in the aptamers market during the forecast period.
The factors such as increasing research and development activities across the world along with the increasing research for the purpose of ensuring the food safety, developing the therapeutics for the targeted delivery and monitoring of the environment has been propelling the growth of the segment in the market during the forecast period.
The factors such as increasing investment for the biotechnological and biopharmaceutical products, along with increasing prevalence of the technology and funding has been propelling the growth of the aptamers market in the region during the forecast period.
The key players in the aptamers market are Ophthotech Corporation, AM Biotechnologies, LLC, Aptagen, LLC, Aptamer Sciences, Inc., Aptus Biotech S.L., Base Pair Biotechnologies, NeoNeuro SAS, Novartis AG, SomaLogic, Inc., Vivonics Inc., NOXXON Pharma and TriLink BioTechnologies among others.
Browse for More Details: https://www.axiommrc.com/product/10519-aptamers-market-report
3 Germay Dr.Ste 4 - 4666
Wilmington DE 19804
U.S.:- + 1 (845) 875-9786
U.K.:- + 44 (0) 20 3286 9707